Skip to main content

Table 3 Multivariate linear regression model for serum cholesterol levels after 6 months of PI-therapy

From: Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Parameter Coefficient p-value R2 a
intercept 59.9 0.071  
Therapy using ATV/r reference   
Therapy using SQV/r 34.5 0.007  
Therapy using FPV/r -83.8 0.15  
FPV/r×BMI at baseline 5.6 0.021  
BMI at baseline 1.5 0.26  
Serum cholesterol at baseline 0.5 < 0.001  
    0.49
  1. a: Coefficient of determination of the regression model